- Latest week
- 10 Jul 2026
- Close
- 0.035000
- Fair value
- 0.026769
- Next-week expectancy
- Negative 37.95%
ENP Chart Pack
Entropy Neurodynamics Limited
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, ENP rose 6.06%, moving from 0.03 to 0.04. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is 2.76 and has improved across the 12-week window. Market Dynamics is -0.06 on the latest week. Next-week expectancy is negative at 37.95% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.04
- 12-Week Change
- 6.06%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 37.95%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 2.76
- Market Dynamics
- -0.06
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.04
- 12-Week Change
- 6.06%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 37.95%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 2.76
- Market Dynamics
- -0.06
Over the latest 12 completed weeks ending 2026-07-10, ENP rose 6.06%, moving from 0.03 to 0.04. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is 2.76 and has improved across the 12-week window. Market Dynamics is -0.06 on the latest week. Next-week expectancy is negative at 37.95% based on similar historical setup states.
Industry Peers
Australia equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| VBS Vectus Biosystems Limited | ASX | 10 Jul 2026 | 0.12 | 0.16 | 0.12 | 0.16 | 33.33% |
| ACW Actinogen Medical Limited | ASX | 10 Jul 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 22.22% |
| ILA Island Pharmaceuticals Limited | ASX | 10 Jul 2026 | 0.38 | 0.55 | 0.38 | 0.45 | 20.00% |
| IMC Immuron Limited | ASX | 10 Jul 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 10.26% |
| MSB Mesoblast Limited | ASX | 10 Jul 2026 | 2.04 | 2.30 | 1.97 | 2.24 | 9.80% |
| BOT Botanix Pharmaceuticals Limited | ASX | 10 Jul 2026 | 0.02 | 0.03 | 0.02 | 0.02 | 9.09% |
| CU6 Clarity Pharmaceuticals Ltd | ASX | 10 Jul 2026 | 2.21 | 2.65 | 2.20 | 2.41 | 9.05% |
| TTX Tetratherix Limited | ASX | 10 Jul 2026 | 5.86 | 6.74 | 5.80 | 6.25 | 6.66% |
| PTX Prescient Therapeutics Limited | ASX | 10 Jul 2026 | 0.07 | 0.08 | 0.07 | 0.07 | 2.86% |
| PYC PYC Therapeutics Limited | ASX | 10 Jul 2026 | 1.53 | 1.60 | 1.49 | 1.56 | 1.63% |
| CSL CSL Limited | ASX | 10 Jul 2026 | 121.85 | 126.98 | 120.75 | 122.89 | 0.85% |
| ANR Anatara Lifesciences Ltd | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00% |
| BIT Biotron Limited | ASX | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| BTC BTC Health Limited | ASX | 10 Jul 2026 | 0.06 | 0.06 | 0.06 | 0.06 | 0.00% |
| IXC Invex Therapeutics Ltd | ASX | 10 Jul 2026 | 0.11 | 0.11 | 0.11 | 0.11 | 0.00% |
| NTI Neurotech International Limited | ASX | 10 Jul 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00% |